Nealbarbital
Tools
Actions
General
Print/export
In other projects
Appearance
From Wikipedia, the free encyclopedia
This is the current revision of this page, as edited by Buidhe (talk | contribs) at 07:41, 7 December 2023 (Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot). The present address (URL) is a permanent link to this version.
Revision as of 07:41, 7 December 2023 by Buidhe (talk | contribs) (Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot)
(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Chemical compound
Clinical data | |
---|---|
Other names | Nealbarbital, Censedal |
ATC code |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.008.386 |
Chemical and physical data | |
Formula | C12H18N2O3 |
Molar mass | 238.287 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Nealbarbital (Censedal) is a barbiturate derivative developed by Aktiebolaget Pharmacia in the 1950s.[1] It has sedative and hypnotic effects, and was used for the treatment of insomnia.
References
[edit]- ^ US Patent 2899435